| Tag | Content |
|---|
EnhancerAtlas ID | HS095-02937 |
Organism | Homo sapiens |
Tissue/cell | HMEC |
Coordinate | chr1:224032310-224033350 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Crx | MA0467.1 | chr1:224032749-224032760 | CTAATCCTCTC | - | 6.02 | | SOX10 | MA0442.2 | chr1:224032919-224032930 | AAAACAAAGCA | + | 6.02 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_09755 | chr1:224031350-224035269 | CD14 | | SE_18793 | chr1:224029943-224035230 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_19882 | chr1:224031522-224035018 | CD4p_CD25-_Il17p_PMAstim_Th17 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | AATATCCCAA ACCCTCTAAA CCCAATTACT AATTCTAGTG AATTGTTAAG TCGACCCAGT 60
GAGAGTTTGG GACGCCCTCC ATGACACAAG CAGGGGGCCA GGGAACAGCA TATTATACTC 120
TGTATGTATG ACTGCAAACT TTGTCATCAC TCCATTCCAC AGACTTCATA AAAGTAAAAG 180
CTTTTTGTTT CTTTGTCTGA ACAAATGGAG CCACAAGCAT AGGATGCCTG CAAGATGTCC 240
CCACTTCAGT GGGAGAGGTG CAAATACAAC TTCCACGAAG AAACTCGCTA CTGAAGTCTG 300
CAGAAGCCAC CGCAACACAC CGCAAACCTC CATTCCGCGA TCGCTGAATG ACAGAGACAT 360
TTCTGAAATG TCTCAAACCT GCTGTTCATC TGTGGCCTGG TGGCCGTGTC AAAAGCCTGC 420
GGAGCTCCTA AAGAAGGCAC TAATCCTCTC CGGAGGTCTT GCTAAAAGCT GTGGGAAACG 480
AAGGGAGCCA GGCACGTACG CTTTCCTGCA ATCTAAAACT TCCGAGATTG CATTTACCAA 540
AACCCCTTTC CACAAAGAGG TAAGGGTGAC TTAGCTGCTA CTGTGGATAT CAAGATCGAA 600
ATTCAATTAA AAACAAAGCA AAGGTACCCG TTCCAGTAAC GTATGTTTCA CTCCAGTAAA 660
AAGTAAAAAG ACACAGCAAA GAACAAGGTC CCCGGTTCCC GTATTCTTGA CCTTCAAGAA 720
CTGCAAAAAA GTCAAGACCC AGTGAAAGAC GAAAAGTTTG AGTGGCTGCT GGGCTCGCGG 780
GCGGCTCGCC TGACTCCGGA GCAGCTGGAG GAACCCGCCT CGAGGTTAGG GTCTCGCCGC 840
GCCCCCACGA CGGCTGTGGG CGCAGAGCCC AGAGGATGGA GCCTCCCCTT CCTGAAACCC 900
GCTCGAAGCT CGGAAAGCCC CGGCCCCTCC GCGCGGGCTG CGGCCCCCAG GCTCCTTCCC 960
CGACGCGCCC GAGGGCGCGG ACCAGCCCCC GGCACGCGAC CCCGCACACT TCCGGGCCCG 1020
ACGCCCTGGC CGCTCGCCCA 1040
|
